Study Evaluating GAP-486 in Heart Rhythm
A Study to Characterize the Acute Electrophysiologic Properties, Safety and Tolerability of GAP-486
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1Y 4W7
-
Toronto, Ontario, Canada, M5B 1W8
-
-
Quebec
-
Montreal, Quebec, Canada, H2L 4M1
-
Montreal, Quebec, Canada, H1T 1CB
-
-
-
-
California
-
San Francisco, California, United States, 94143
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20010
-
-
Pennsylvania
-
Hershey, Pennsylvania, United States, 17033
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients undergoing an electrophysiology study for evaluation of heart rhythm.
Exclusion Criteria:
- Patients with uncontrolled blood pressure
- Patients with certain cardiac risk factors
- Patients with significant kidney or liver problems
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
|---|
|
This study takes place within 24 hours. The measure to determine the effect of the intervention will be the difference in values from the baseline electrophysiology study, and the values obtained after intervention within the test drug.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
|---|
|
This study takes place within 24 hours, and looks at the changes in values of electrophysiology studies, before and after administration of test article.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 3163K1-201
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.